1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Epiomic Epidemiology Series: Autism Spectrum Disorders Forecast in 12 Major Markets 2015-2025

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Autism Spectrum Disorders in 12 Major Markets

Autism Spectrum Disorders (ASD) or Pervasive Developmental Disorder (PDD) defines a group of developmental disability disorders. In this report, disorders include: Autism, Pervasive Developmental Disorder not otherwise specified (PDD-NOS) and Asperger Syndrome. Attributes of these disorders can be grouped into three areas: communication difficulties, repetitive and stereotyped behaviour and social impairment, with a wide variation of symptoms which can occur for any given patient.

This report provides the current prevalent population for ASD across 12 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, India, Denmark, Sweden and China) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the type and severity of ASD, level of cognitive function and behavioural and motor dysfunction. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of ASD have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for ASD include:

-ADHD
-Epilepsy
-Gastrointestinal problems
-Motor function/ co-ordination problems
-Anxiety
-Depression
-Hypotonia
-Restless Sleep

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global ASD’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of ASD and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Provide a level of understanding on the impact from specific co-morbid conditions on ASD’s prevalent population.
-Identify sub-populations within ASD which require treatment.
-Gain an understanding of the specific markets that have the largest number of ASD patients.

Table Of Contents

Epiomic Epidemiology Series: Autism Spectrum Disorders Forecast in 12 Major Markets 2015-2025
Autism Spectrum Disorders
Table of Contents
-List of Tables and Figures
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis andClinical Course
-Key Co-morbid Conditions/ Features Associated with the Disease
-Methodology for Quantification of Patient Numbers
-Top-Line Prevalence for Autism Spectrum Disorders (ASD)
-Main Complications and Features of ASD
o Type of ASD
o Severity of ASD
o Level of Cognitive Function in ASD Patients
o The Seizure Type in ASD Patients with Epilepsy
o Behavioural Dysfunction in ASD Patients
o Motor and Muscle Impairment in ASD Patients
-Abbreviations used in the Report
-Other Black Swan Analysis Publications
-Black Swan Analysis Online Patient-Based Databases
-Patient-Based Offering
-Online Pricing Data and Platforms
-References
-Appendix


List of Tables and Figures
-Prevalence of ASD, total (000s)
-Prevalence of ASD, males (000s)
-Prevalence of ASD, females (000s)
-Prevalence of ASD from birth to 19 years of age, total (000s)
-Prevalence of ASD from birth to 19 years of age, males (000s)
-Prevalence of ASD from birth to 19 years of age, females (000s)
-Type of ASD, total (000s)
-Severity of ASD, total (000s)
-Cognitive Function of ASD patients by IQ score, total (000s)
-Gastrointestinal Symptoms of ASD patients, total (000s)
-Epileptic Seizure Types in ASD patients, total (000s)
-Number of Hours Slept in ASD patients, total (000s)
-ADHD in ASD Patients, total (000s)
-OCD in Asperger's syndrome patients, total (000s)
-Anxiety Disorder in ASD patients, total (000s)
-Depression Disorder in ASD patients, total (000s)
-Gross Motor Delay in ASD patients, total (000s)
-Hypotonia in ASD patients, total (000s)
-Abbreviations and acronyms used in the Report
-USA Prevalence of ASD by 5-yr age cohort, males (000s)
-USA Prevalence of ASD by 5-yr age cohort, females (000s)
-France Prevalence of ASD by 5-yr age cohort, males (000s)
-France Prevalence of ASD by 5-yr age cohort, females (000s)
-Germany Prevalence of ASD by 5-yr age cohort, males (000s)
-Germany Prevalence of ASD by 5-yr age cohort, females (000s)
-Italy Prevalence of ASD by 5-yr age cohort, males (000s)
-Italy Prevalence of ASD by 5-yr age cohort, females (000s)
-Spain Prevalence of ASD by 5-yr age cohort, males (000s)
-Spain Prevalence of ASD by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of ASD by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of ASD by 5-yr age cohort, females (000s)
-Brazil Prevalence of ASD by 5-yr age cohort, males (000s)
-Brazil Prevalence of ASD by 5-yr age cohort, females (000s)
-Japan Prevalence of ASD by 5-yr age cohort, males (000s)
-Japan Prevalence of ASD by 5-yr age cohort, females (000s)
-India Prevalence of ASD by 5-yr age cohort, males (000s)
-India Prevalence of ASD by 5-yr age cohort, females (000s)
-Denmark Prevalence of ASD by 5-yr age cohort, males (000s)
-Denmark Prevalence of ASD by 5-yr age cohort, females (000s)
-Sweden Prevalence of ASD by 5-yr age cohort, males (000s)
-Sweden Prevalence of ASD by 5-yr age cohort, females (000s)
-China Prevalence of ASD by 5-yr age cohort, males (000s)
-China Prevalence of ASD by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

Epilepsy  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Epilepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...

Narcolepsy-Market Insights, Epidemiology and Market Forecast-2023

Narcolepsy-Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Narcolepsy - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.